(Q36649087)

15 August 2017

1 reference

title

Pharmacotherapy of bipolar depression: an update (English)

1 reference

15 August 2017

0 references

1 reference

Michael E Thase

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Current Psychiatry Reports

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

478-488

1 reference

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-006-0055-6

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-006-0055-6

Treatment of imipramine-resistant recurrent depression, IV: A double- blind crossover study of tranylcypromine for anergic bipolar depression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-006-0055-6

Safety and tolerability of lamotrigine for bipolar disorder

21 January 2018

1 reference

12 December 2020

The increasing medical burden in bipolar disorder

1 reference

12 December 2020

Suicidal behaviour in bipolar disorder: risk and prevention

1 reference

12 December 2020

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

12 December 2020

Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?

1 reference

12 December 2020

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

1 reference

12 December 2020

Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data

1 reference

12 December 2020

Is bipolar II a unique disorder?

1 reference

12 December 2020

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

12 December 2020

Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders

1 reference

12 December 2020

Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature

1 reference

12 December 2020

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

12 December 2020

Predictors of bipolar illness in adolescents with major depression: a follow-up investigation

1 reference

12 December 2020

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases

1 reference

12 December 2020

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

1 reference

12 December 2020

Divalproex in the treatment of bipolar depression: a placebo-controlled study

1 reference

12 December 2020

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

12 December 2020

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.

1 reference

12 December 2020

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group

1 reference

12 December 2020

Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder

1 reference

12 December 2020

Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania

1 reference

12 December 2020

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

12 December 2020

Antidepressant monotherapy for bipolar type II major depression

1 reference

12 December 2020

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

12 December 2020

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

1 reference

12 December 2020

A double-blind trial of bupropion versus desipramine for bipolar depression

1 reference

12 December 2020

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

12 December 2020

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

1 reference

12 December 2020

Switching From 'Unipolar' to Bipolar II

1 reference

12 December 2020

Screening for bipolar disorder in the community

1 reference

12 December 2020

Bipolar depression: issues in diagnosis and treatment

1 reference

12 December 2020

Bipolar disorder--a seriously underestimated health burden

1 reference

12 December 2020

Bipolar depression: an underestimated treatment challenge

1 reference

12 December 2020

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

12 December 2020

Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials

1 reference

12 December 2020

Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

1 reference

12 December 2020

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

12 December 2020

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

12 December 2020

Maintenance efficacy of divalproex in the prevention of bipolar depression

1 reference

12 December 2020

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

12 December 2020

Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.

1 reference

12 December 2020

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

12 December 2020

Developmental Pathways to Bipolarity: Are Juvenile-Onset Depressions Pre-Bipolar?

1 reference

12 December 2020

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

1 reference

12 December 2020

A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

1 reference

12 December 2020

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

12 December 2020

Early symptoms of mania and the role of parental risk.

1 reference

12 December 2020

Stabilization in the treatment of mania, depression and mixed states

1 reference

12 December 2020

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

12 December 2020

Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression

1 reference

12 December 2020

Beyond lithium in the treatment of bipolar illness

1 reference

12 December 2020

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

12 December 2020

Bipolar depression: pharmacotherapy and related therapeutic strategies

1 reference

12 December 2020

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate

1 reference

12 December 2020

Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder

1 reference

12 December 2020

Venlafaxine monotherapy in women with bipolar II and unipolar major depression

1 reference

12 December 2020

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

12 December 2020

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

12 December 2020

Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania

1 reference

12 December 2020

Trends in the treatment of bipolar disorder by outpatient psychiatrists

1 reference

12 December 2020

Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy

1 reference

12 December 2020

Bipolar disorder therapeutics: maintenance treatment

1 reference

12 December 2020

Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003.

1 reference

12 December 2020

10.1007/S11920-006-0055-6

Identifiers

DOI

1 reference

15 August 2017

1 reference